Get 20% lifetime commission for referring investors to digrin.com
here.
Immunic, Inc. ( IMUX) - Key Metrics
IMUX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.80 | -$0.73 | -$0.73 |
| 2026Q1 | $0 | -$10.81 | -$5.74 | -$5.74 |
| 2025Q4 | $0 | -$12.40 | -$12.38 | -$12.39 |
| 2025Q3 | $0 | -$13.19 | -$10.39 | -$10.42 |
| 2025Q2 | $0 | -$20.29 | -$18.62 | -$18.65 |
IMUX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.80 |
| 2026Q1 | 0% | -2.57 |
| 2025Q4 | 0% | -0.83 |
| 2025Q3 | 0% | -1.70 |
| 2025Q2 | 0% | -0.87 |
IMUX
Price: $16.83
52 week price:
Earnings Per Share: -3.67 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 562646
Market Capitalization: 217.4 million